InfuSystem Holdings (INFU) Change in Accured Expenses (2010 - 2026)

InfuSystem Holdings (INFU) posted Change in Accured Expenses of -$3.3 million for Q1 2026, down 478.78% on a QoQ basis from -$575000.0 in Q4 2025, and down 111.03% year-over-year from $30.2 million in Q1 2025.

InfuSystem Holdings (INFU) Change in Accured Expenses (2010 - 2026) Analysis & Trends

InfuSystem Holdings' Change in Accured Expenses history runs 11 years deep, the most recent figure standing at -$3.3 million for Q1 2026.

  • Quarterly Change in Accured Expenses fell 111.03% year-over-year to -$3.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.5 million (down 114.39% YoY) and the FY2025 annual result came in at -$708000.0, down 4.73% from the prior year.
  • Change in Accured Expenses was -$3.3 million for Q1 2026 at InfuSystem Holdings, down from -$575000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $2.7 million in Q4 2023 and bottomed at -$3.3 million in Q1 2026.
  • A 5-year average of $37941.2 and a median of $313000.0 in 2023 frame the typical range for Change in Accured Expenses.
  • Annual changes were most pronounced in 2022 — Change in Accured Expenses surged 194.16% — and 2024, when it sank 453.35%.
  • InfuSystem Holdings' Change in Accured Expenses stood at $1.7 million in 2022, then soared by 55.22% to $2.7 million in 2023, then tumbled by 79.55% to $553000.0 in 2024, then plunged by 203.98% to -$575000.0 in 2025, then tumbled by 478.78% to -$3.3 million in 2026.
  • Business Quant data shows INFU's Change in Accured Expenses at -$3.3 million in Q1 2026, -$575000.0 in Q4 2025, and $1.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -654.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 123.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -512.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -347.10 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 145.10 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 21.07 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -250.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 InfuSystem Holdings 179.47 Mn 177.37 Mn 19.68 Mn -3.33 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.33 Mn
Mar 31, 2026 -3.33 Mn
Dec 31, 2025 -575,000.00
Dec 31, 2025 -575,000.00
Sep 30, 2025 1.84 Mn
Sep 30, 2025 1.84 Mn
Jun 30, 2025 -398,000.00
Jun 30, 2025 -398,000.00
Mar 31, 2025 -1.58 Mn
Mar 31, 2025 -1.58 Mn
Dec 31, 2024 553,000.00
Dec 31, 2024 553,000.00
Sep 30, 2024 2.04 Mn
Sep 30, 2024 2.04 Mn
Jun 30, 2024 -2.16 Mn
Jun 30, 2024 -2.16 Mn
Mar 31, 2024 -1.11 Mn
Mar 31, 2024 -1.11 Mn
Dec 31, 2023 2.70 Mn
Dec 31, 2023 2.70 Mn